| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $4.3M | +1149.0% |
| Cost of Revenue | $14.9M | +7452.1% |
| Gross Profit | -$10.6M | -257.1% |
| R&D Expense | $8.5M | -40.9% |
| SG&A Expense | $21.2M | +31.3% |
| Operating Income | -$42.0M | +12.0% |
| Interest Expense | $0 | — |
| Net Income | -$46.8M | +10.9% |
| EPS (Basic) | -$0.58 |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.5M | +6.7% |
| Accounts Receivable | $2.8M | +1125.2% |
| Inventory | $408K | +164.5% |
| Current Assets | $29.5M | +60.4% |
| Total Assets | $84.5M | +8.7% |
| Current Liabilities | $13.7M | -13.5% |
| Long-term Debt | $2.1M | -70.4% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.9M | -72.8% |
| Investing Cash Flow | -$2.5M | +80.3% |
| Financing Cash Flow | $36.9M | +7.4% |
| +43.1% |
| EPS (Diluted) | -$0.58 | +43.1% |
| Total Liabilities |
| $13.9M |
| -14.5% |
| Stockholders' Equity | $70.6M | +14.9% |